Gyre Therapeutics Announces China’s Nmpa Approval of Avatrombopag Maleate Tablets for the Treatment of Cld-Associated Thrombocytopenia
Gyre Therapeutics宣佈中國國家藥品監督管理局已批准Avatrombopag Maleate片劑用於治療CLD相關血小板減少症。
Gyre Therapeutics Announces China’s Nmpa Approval of Avatrombopag Maleate Tablets for the Treatment of Cld-Associated Thrombocytopenia
Gyre Therapeutics宣佈中國國家藥品監督管理局已批准Avatrombopag Maleate片劑用於治療CLD相關血小板減少症。
使用瀏覽器的分享功能,分享給你的好友吧